Literature DB >> 26373413

Tachykinins Processing is Significantly Impaired in PC1 and PC2 Mutant Mouse Spinal Cord S9 Fractions.

Mouna Saidi1, Soufiane Kamali1, Alberto Orduna Ruiz1, Francis Beaudry2.   

Abstract

Substance P (SP) play a central role in nociceptive transmission and it is an agonist of the Neurokinin-1 receptor located in the lamina I of the spinal cord. SP is a major proteolytic product of the protachykinin-1 primarily synthesized in neurons. Proprotein convertases (PCs) are extensively expressed in the central nervous system and specifically cleave at C-terminal of either a pair of basic amino acids, or a single basic residue. The proteolysis control of endogenous protachykinins has a profound impact on pain perception and the role of PCs remain unclear. The objective of this study was to decipher the role of PC1 and PC2 in the proteolysis surrogate protachykinins (i.e. Tachykinin 20-68 and Tachykinin 58-78) using cellular fractions of spinal cords from wild type (WT), PC1(-/+) and PC2(-/+) animals and mass spectrometry. Full-length Tachykinin 20-68 and Tachykinin 58-78 was incubated for 30 min in WT, PC1(-/+) and PC2(-/+) mouse spinal cord S9 fractions and specific C-terminal peptide fragments were identified and quantified by mass spectrometry. The results clearly demonstrate that both PC1 and PC2 mediate the formation of SP and Tachykinin 58-71, an important SP precursor, with over 50 % reduction of the rate of formation in mutant PC1 and PC2 mouse S9 spinal cord fractions. The results obtained revealed that PC1 and PC2 are involved in the C-terminal processing of protachykinin peptides and suggest a major role in the maturation of the protachykinin-1 protein.

Entities:  

Keywords:  Mass spectrometry; Pain; Proprotein convertases; Proteolysis; Spinal cords; Substance P; Tachykinin

Mesh:

Substances:

Year:  2015        PMID: 26373413     DOI: 10.1007/s11064-015-1720-0

Source DB:  PubMed          Journal:  Neurochem Res        ISSN: 0364-3190            Impact factor:   3.996


  24 in total

Review 1.  A review on electron microscopy and neurotransmitter systems.

Authors:  Fernando Torrealba; Maria Angélica Carrasco
Journal:  Brain Res Brain Res Rev       Date:  2004-12

Review 2.  Neuropeptide-processing enzymes: applications for drug discovery.

Authors:  Lloyd D Fricker
Journal:  AAPS J       Date:  2005-10-05       Impact factor: 4.009

Review 3.  Proteases for processing proneuropeptides into peptide neurotransmitters and hormones.

Authors:  Vivian Hook; Lydiane Funkelstein; Douglas Lu; Steven Bark; Jill Wegrzyn; Shin-Rong Hwang
Journal:  Annu Rev Pharmacol Toxicol       Date:  2008       Impact factor: 13.820

4.  Role of prohormone convertases in pro-neuropeptide Y processing: coexpression and in vitro kinetic investigations.

Authors:  N Brakch; B Rist; A G Beck-Sickinger; J Goenaga; R Wittek; E Bürger; H R Brunner; E Grouzmann
Journal:  Biochemistry       Date:  1997-12-23       Impact factor: 3.162

Review 5.  Sensitivity enhancement in liquid chromatography/atmospheric pressure ionization mass spectrometry using derivatization and mobile phase additives.

Authors:  Songmei Gao; Zong-Ping Zhang; H T Karnes
Journal:  J Chromatogr B Analyt Technol Biomed Life Sci       Date:  2005-10-25       Impact factor: 3.205

6.  Primary afferent tachykinins are required to experience moderate to intense pain.

Authors:  Y Q Cao; P W Mantyh; E J Carlson; A M Gillespie; C J Epstein; A I Basbaum
Journal:  Nature       Date:  1998-03-26       Impact factor: 49.962

Review 7.  Neuropeptidomic components generated by proteomic functions in secretory vesicles for cell-cell communication.

Authors:  Vivian Hook; Steven Bark; Nitin Gupta; Mark Lortie; Weiya D Lu; Nuno Bandeira; Lydiane Funkelstein; Jill Wegrzyn; Daniel T O'Connor; Pavel Pevzner
Journal:  AAPS J       Date:  2010-08-24       Impact factor: 4.009

8.  Peripheral substance P and neurokinin-1 receptors have a role in inflammatory and neuropathic orofacial pain models.

Authors:  Fernanda C Teodoro; Marcos F Tronco Júnior; Aleksander R Zampronio; Alessandra C Martini; Giles A Rae; Juliana G Chichorro
Journal:  Neuropeptides       Date:  2012-11-22       Impact factor: 3.286

9.  Treatment with either high or low frequency TENS reduces the secondary hyperalgesia observed after injection of kaolin and carrageenan into the knee joint.

Authors:  K A Sluka; K Bailey; J Bogush; R Olson; A Ricketts
Journal:  Pain       Date:  1998-07       Impact factor: 6.961

10.  Inhibitors of endopeptidase and angiotensin-converting enzyme lead to an amplification of the morphological changes and an upregulation of the substance P system in a muscle overuse model.

Authors:  Yafeng Song; Per S Stål; Ji-Guo Yu; Ronny Lorentzon; Clas Backman; Sture Forsgren
Journal:  BMC Musculoskelet Disord       Date:  2014-04-11       Impact factor: 2.362

View more
  1 in total

1.  Deciphering the Role of EGL-3 for Neuropeptides Processing in Caenorhabditis elegans Using High-Resolution Quadrupole-Orbitrap Mass Spectrometry.

Authors:  Jennifer Ben Salem; Bruno Nkambeu; Dina N Arvanitis; Francis Beaudry
Journal:  Neurochem Res       Date:  2018-09-18       Impact factor: 3.996

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.